ArticleVaccines2024

Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study.

Guillermo Ezpeleta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.